These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31183782)

  • 21. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance.
    ; ;
    Health Qual Life Outcomes; 2006 Oct; 4():79. PubMed ID: 17034633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a patient-reported outcome measure for psychotherapeutic interventions in people with seizures: A mixed methods study.
    Michaelis R; Meyer S; Reuber M; Schöne C
    Epilepsy Behav; 2019 Oct; 99():106464. PubMed ID: 31421518
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-Centered Research to Support the Development of the Symptoms of Major Depressive Disorder Scale (SMDDS): Initial Qualitative Research.
    McCarrier KP; Deal LS; Abraham L; Blum SI; Bush EN; Martin ML; Thase ME; Coons SJ;
    Patient; 2016 Apr; 9(2):117-34. PubMed ID: 26113249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of the chronic obstructive pulmonary disease morning symptom diary (COPD-MSD).
    Globe G; Currie B; Leidy NK; Jones P; Mannino D; Martinez F; Klekotka P; O'Quinn S; Karlsson N; Wiklund I
    Health Qual Life Outcomes; 2016 Jul; 14(1):104. PubMed ID: 27424173
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Vulvodynia Experience Questionnaire: Qualitative Development of a New Patient-Reported Outcome Measure for Vulvodynia.
    Goldstein AT; Diez PMQ; Kapanadze S; Cala ML; Evans CJ; Whyte JL; Christoph A
    J Sex Med; 2020 Oct; 17(10):2055-2066. PubMed ID: 32900670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incorporating development of a patient-reported outcome instrument in a clinical drug development program: examples from a heart failure program.
    Wiklund I; Anatchkova M; Oko-Osi H; von Maltzahn R; Chau D; Malik FI; Patrick DL; Spertus J; Teerlink JR
    Health Qual Life Outcomes; 2016 Sep; 14(1):131. PubMed ID: 27629389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an Item Bank to Assess Patient-Reported Outcomes: Signs, Symptoms, and Impacts of COVID-19.
    Reaney M; Turnbull J; Paty J; Heuer K; Gwaltney C
    Patient; 2022 Nov; 15(6):703-713. PubMed ID: 35857266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of the symptoms and impacts questionnaire for Crohn's disease and ulcerative colitis.
    Dulai PS; Jairath V; Khanna R; Ma C; McCarrier KP; Martin ML; Parker CE; Morris J; Feagan BG; Sandborn WJ
    Aliment Pharmacol Ther; 2020 Jun; 51(11):1047-1066. PubMed ID: 32319120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective development of a patient-reported outcomes instrument for desmoid tumors or aggressive fibromatosis.
    Gounder MM; Maddux L; Paty J; Atkinson TM
    Cancer; 2020 Feb; 126(3):531-539. PubMed ID: 31691276
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a New Tool for Evaluating the Benefit of Preventive Treatments for Migraine on Functional Outcomes - The Migraine Functional Impact Questionnaire (MFIQ).
    Hareendran A; Skalicky A; Mannix S; Lavoie S; Desai P; Bayliss M; Thach AV; Mikol DD; Buse DC
    Headache; 2018 Nov; 58(10):1612-1628. PubMed ID: 30374958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Assessing the patient experience of respiratory syncytial virus infection: development of a patient-reported outcome measure.
    Romano CD; Finelli L; Lewis S; Williams V; Martin E; Phillips M; Saretsky TL; Norquist J
    Health Qual Life Outcomes; 2023 Feb; 21(1):20. PubMed ID: 36855175
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and content validity testing of a patient-reported outcomes questionnaire for the assessment of hereditary angioedema in observational studies.
    Bonner N; Abetz-Webb L; Renault L; Caballero T; Longhurst H; Maurer M; Christiansen S; Zuraw B;
    Health Qual Life Outcomes; 2015 Jul; 13():92. PubMed ID: 26129930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Qualitative Study to Develop and Evaluate the Content Validity of the Vitiligo Patient Priority Outcome (ViPPO) Measures.
    Kitchen H; Gandhi K; Carmichael C; Wyrwich KW; Lukic T; Al-Zubeidi T; Marshall C; Pegram H; King S; King B
    Dermatol Ther (Heidelb); 2022 Aug; 12(8):1907-1924. PubMed ID: 35857279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Understanding treatment burden in hemophilia: development and validation of the Hemophilia Treatment Experience Measure (Hemo-TEM).
    Brod M; Bushnell DM; Neergaard JS; Waldman LT; Busk AK
    J Patient Rep Outcomes; 2023 Feb; 7(1):17. PubMed ID: 36821002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of the Diary for Irritable Bowel Syndrome Symptoms to Assess Treatment Benefit in Clinical Trials: Foundational Qualitative Research.
    Fehnel SE; Ervin CM; Carson RT; Rigoni G; Lackner JM; Coons SJ;
    Value Health; 2017 Apr; 20(4):618-626. PubMed ID: 28408004
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Modular Health-Related Quality of Life Instrument for Electronic Assessment and Treatment Monitoring: Web-Based Development and Psychometric Validation of Core Thrive Items.
    Wicks P; McCaffrey S; Goodwin K; Black R; Hoole M; Heywood J
    J Med Internet Res; 2019 Jan; 21(1):e12075. PubMed ID: 30681962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CDI-DaySyms: Content Development of a New Patient-Reported Outcome Questionnaire for Symptoms of Clostridium difficile Infection.
    Kleinman L; Talbot GH; Hunsche E; Schüler R; Nord CE
    Value Health; 2018 Apr; 21(4):441-448. PubMed ID: 29680101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and content validity of the Lupus Foundation of America rapid evaluation of activity in lupus (LFA-REAL™): a patient-reported outcome measure for lupus disease activity.
    Askanase AD; Daly RP; Okado M; Neville K; Pong A; Hanrahan LM; Merrill JT
    Health Qual Life Outcomes; 2019 Jun; 17(1):99. PubMed ID: 31174541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations on evidence needed to support measurement equivalence between electronic and paper-based patient-reported outcome (PRO) measures: ISPOR ePRO Good Research Practices Task Force report.
    Coons SJ; Gwaltney CJ; Hays RD; Lundy JJ; Sloan JA; Revicki DA; Lenderking WR; Cella D; Basch E;
    Value Health; 2009 Jun; 12(4):419-29. PubMed ID: 19900250
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of a patient-reported outcome (PRO) measure to assess patient perceptions of simplicity and complexity of treatment for type 2 diabetes.
    Stewart KD; Matza LS; Patel H; Boye KS
    J Patient Rep Outcomes; 2023 Sep; 7(1):89. PubMed ID: 37672123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.